Impaired survival and long-term neurological problems in benign meningioma

Neuro-Oncology

Volumn 14, Issue 5, 2012, Pages 658-666

  Van Alkemade, Hanna ^a,b   De Leau, Michelle ^a,b   Dieleman, Edith M T ^a   Kardaun, Jan W P F ^c   Van Os, Rob ^a   Vandertop, W Peter ^b   Van Furth, Wouter R ^b   Stalpers, Lukas J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Neurosurgical Center Amsterdam   (Netherlands)

^c STATISTICS NETHERLANDS   (Netherlands)

Author keywords

Adverse effects; Meningioma; Neurosurgery; Radiotherapy; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; STROKE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; NERVOUS SYSTEM DISEASES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 84860369071     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos013     Document Type: Article

References (51)

1. CBTRUS Central Brain Tumour Registry of the United States (2011). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. website: www.cbtrus.org. Accessed February 11, 2012.
2. Larjavaara S, Haapasalo H, Sankila R, Helén P, Auvinen A. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer. 2008;99:182-184.
3. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol. 2007;114:97-109.
4. Marosi C, Hassler M, Roessler K, et al. Meningioma. Crit Rev Oncol Hematol. 2008;67:153-171.
5. Norden AD, Drapatz J, Wen PY. Advances in meningioma therapy. Curr Neurol Neurosci Rep. 2009;9:231-240.
6. Gondi V, Tome WA, Mehta MP. Fractionated radiotherapy for intracranial meningiomas. J Neurooncol. 2010;99:349-356.
7. Dijkstra M, van Nieuwenhuizen D, Stalpers LJ, et al. Late neurocognitive sequelae in patients with WHO grade I meningioma. J Neurol Neurosurg Psychiatry. 2009;80:910-915.
8. van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol. 2007;84:271-278.
9. Waagemans ML, van Nieuwenhuizen D, Dijkstra M, et al. Long-term impact of cognitive deficits and epilepsy on quality of life in low-grade meningioma patients. Neurosurgery. 2011;69:72-79.
10. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol. 1993;3:255-268.
11. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20:22-39.
12. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod, CM, ed. Evaluation of Chemotherapeutic Agents. Columbia Univ Press, 1949:196.
13. NCI-National Cancer Institute. Common Toxicity Criteria v2.0. 1999. CTEP-NCI-NIH, Bethesda, MD. Available at http://ctep.cancer.gov. Accessed February 11, 2012.
14. Talbä ck M, Stenbeck M, Rosén M. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer. 2004;40:1361-1372.
15. Cahill KS, Claus EB. Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Clinical article. J Neurosurg. 2011;115(2):259-267.
16. Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F. Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol. 2004;71:85-90.
17. Percy C, Fritz A, Jack A, et al. WHO-World Health Organization. International Classification of Diseases for Oncology (ICD-O). 3rd ed. World Health Organization, Geneva, 2000.
18. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57:1088-1095.
19. ACS-American Cancer Society. 2011. http://www.cancer.org.
20. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:1-23.
21. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821-1828.
22. Stalpers LJ, Dieleman EM, van Westing BR, Postma TJ, van Furth WR. [Diagnosis and treatment of brain tumors]. Ned Tijdschr Tandheelkd. 2009;116:202-207.
23. McCarthy BJ, Davis FG, Freels S, et al. Factors associated with survival in patients with meningioma. J Neurosurg. 1998;88:831-839.
24. Bateman BT, Pile-Spellman J, Gutin PH, Berman MF. Meningioma resection in the elderly: nationwide inpatient sample, 1998-2002. Neurosurg. 2005;57:866-872.
25. Curry WT, McDermottMW, Carter BS, Barker FG. Craniotomy for meningioma in the United States between 1888 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg. 2005;102:977-986.
26. Sughrue ME, Kane AJ, Shangari G, et al. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg. 2010;113: 1029-1035.
27. Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg. 1983;58:51-66.
28. Forbes AR, Goldberg ID. Radiation therapy in the treatment of meningioma: The Joint Center for Radiation Therapy experience 1970 to 1982. J Clin Oncol. 1984;2:1139-1143.
29. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62:18-24.
30. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery. 1987;20:525-528.
31. Taylor BW, Marcus RB, Friedman WA, Ballinger WE, Million RR. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1988;15:299-304.
32. Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys. 1990;18:755-761.
33. Miralbell R, Linggood RM, de la Monte MS, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol. 1992;13:157-164.
34. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990 [published erratum appears in J Neurosurg 1994;80:777]. J Neurosurg. 1994;80:195-201.
35. Mahmood A, Qureshi NH, Malik GM. Intracranial meningiomas: analysis of recurrence after surgical treatment. Acta Neurochir (Wien). 1994;126:53-58.
36. Peele KA, Kennerdell JS, Maroon JC, et al. The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report. Ophthalmology. 1996;103:1761-1766.
37. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB, Jr., Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997;39:427-436.
38. Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998;73:936-942.
39. Maguire PD, Clough R, Friedman AH, Halperin EC. Fractionated external-beam radiation therapy for menigiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys. 1999;44:75-79.
40. Nutting C, Brada M, Brazil L, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg. 1999;90:823-827.
41. Vendrely V, Maire JP, Darrouzet V, et al. Radiothé rapie fractionné e des mé ningiomes intracrâ niens: 15 ans d'expé rience au centre hospitalier universitaire de Bordeaux. [Fractionated radiotherapy of intracranial meningiomas: 15 years' experience at the Bordeaux University Hospital Center]. Cancer Radiother. 1999;3:311-317.
42. Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg. 1999;91:44-50.
43. Wenkel E, Thornton AF, Finkelstein D, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1363-1370.
44. Dufour H, Muracciole X, Metellus P, Regis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. 2001;48:285-294.
45. Debus J, Wuendrich M, Pirzkall A, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol. 2001;19:3547-3553.
46. Pourel N, Auque J, Bracard S, et al. Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience. Radiother Oncol. 2001;61:65-70.
47. Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small-to medium-size meningiomas. Int J Radiat Oncol Biol Phys. 2003;55:1000-1005.
48. Selch MT, Ahn E, Laskari A, et al. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2004;59:101-111.
49. Henzel M, Gross MW, Hamm K, et al. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol. 2006;182:382-388.
50. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys. 2007;68:858-863.
51. Honig S, Trantakis C, Frerich B, Sterker I, Kortmann RD, Meixensberger J. Meningiomas Involving the Sphenoid Wing Outcome after Microsurgical Treatment-A Clinical Review of 73 Cases. Cen Eur Neurosurg. 2010;71:189-198.